InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,890.26
(
1.86%
)
US TECH 100
20,126.00
(
2.22%
)
Dow Jones
43,529.73
(
3.10%
)
Brent Oil
75.54
(
0.19%
)
Bitcoin
74,289.89
(
7.18%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

cvinvestor

Send PM Follow Ignore
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

cvinvestor

Re: angelicsatan666 post# 111061

Wednesday, 03/05/2014 11:06:12 AM

Wednesday, March 05, 2014 11:06:12 AM

Post# of 158400
Yes, the one mistake I saw was a misspelling on one occasion of HemaXellerate as HemaXellaerate.

Whether or not that would disqualify a filing I will leave up to any expert on FDA filings. The misspelling is in a descriptive area and not a defining area, but I don't know how much that matters.

Certainly, if the filing response is: "The only mistake we found is one variation of the spelling of HemaXellerate as HemaXellaerate", then I would not think it will take very long to correct for approval.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up